An implant for occluding a left atrial appendage may include an expandable framework including a body portion and a disk portion, wherein the expandable framework is configured to shift between a collapsed configuration and an expanded configuration, and an occlusive disk element disposed within the disk portion. The disk portion may include a first disk portion integrally formed with the body portion, and a second disk portion movably attached to the first disk portion by at least one hinge member.

The invention relates to a novel multivalent atrial appendage occluder of hybrid design based on two different atrial appendage occluders, one having a proximal disk-shaped cover and a second version without a proximal cover. The two occluder variants each provide relevant application solutions by themselves. The invention further relates to multiple specified, universal devices composed of predominantly rotationally symmetrical individual parts for producing these different LAA occluders (LAA=Left Atrial Appendage) which are graded in different sizes, for the interventional, catheter-based closure of the left atrial appendage. Axially and radially oriented hooks support the secure and gentle anchoring of the occluders 1 in the retaining area of the atrial appendage 26. As a result, the use of substantially smaller access ports in the interventional application is possible. The two atrial appendage occluder variants, with and without proximal cover 14, can be inserted using the same controllable access port and can be implanted in various sizes individually or in combination with one another and likewise as a hybrid variant of two occluders, one without a proximal cover (14) and one subsequently with a proximal cover (14) in one and the same atrial appendage (24) as shown in FIG. 17. The two atrial appendage occluder variants can each be released during the implantation phase in three stages until they are fully unfolded.

A left atrial appendage (LAA) occluder and an occluding system are provided. The LAA occluder includes a sealing portion and an ablation portion arranged in the sealing portion, as well as a hollow proximal connector at a proximal end of the sealing portion. The ablation portion is connected to the proximal connector. The ablation portion is used to freeze an LAA after being injected with cryogen so as to form an annular isolation band on an inner wall of the LAA for blocking the conduction of electrical signals between the LAA and a left atrium.

Devices, methods, and systems for closure device for a left atrial appendage and, in particular, to a closure device that includes an anchor element and a disc element that are each individually chosen based on the anatomy of the patient's left atrial appendage and assembled before implantation. In one embodiment, a medical device comprises: an anchor element, the anchor element including a first connection element; and a disc element, the disc element including a second connection element pivotably coupled to the first connection element, the anchor element being sized to be received and retained within a left atrial appendage and the disc element being sized to completely cover an opening of the left atrial appendage.

A device for placement in vessels, appendages, and openings in a body, the device comprising: a frame having a plurality of elongate members, the frame including: a substantially uniform proximal end of the frame having (i) a center frame portion arranged at the proximal end and (ii) face portions of the plurality of elongate members extending from the center frame portion and including a curved pattern arranged substantially within a first plane approximately perpendicular to a longitudinal axis of the frame; a body portion; a membrane coupled to at least the substantially uniform proximal end of the frame; and a coating arranged on at least a portion of the membrane configured to minimize the thrombogenic response of blood contact with the membrane.

A medical instrument (1000) includes a stent (100) and a constraining structure (300). The constraining structure (300) constrains, and thereby prevents tangling of, a trailing section of the stent (100), ensuring successful release of the stent (100). Specifically, the stent (100) has a first proximal end and an opposing first distal end. The first distal end is configured with an expanded configuration and a collapsed configuration. The trailing section at the first distal end includes a number of protrusions (111). The constraining structure (300) includes a body (310) and a clamping mechanism (320). The clamping mechanism (320) is disposed at a distal end of the body (310), and the body (310) extends from the first proximal end to the first distal end. The clamping mechanism (320) limits relative movement and thus prevents tangling of the protrusions (111) by passing through all or some of the protrusions (111). Additionally, it allows the stent (100) to be less deformed within a delivery sheath and thereby enables it to successfully expand when pushed out of the sheath.

An implant for occluding a left atrial appendage may include an expandable framework configured to shift between a collapsed configuration and an expanded configuration. The expandable framework includes a proximal hub and a distal hub. A longitudinal axis of the expandable framework extends from the proximal hub to the distal hub. A radiopaque marker may be positioned longitudinally between the proximal hub and the distal hub in the expanded configuration.

The present invention describes systems and methods for treating the left atrial appendage with an implant to fluidly seal the left atrial appendage and prevent blood from flowing from the left atrial appendage to the left atrium. The closure implant includes a braided disk, a proximal petal anchor and a distal petal anchor positioned on an implant shaft. The braided disk includes two diameters: a proximal diameter sized to engage a wall area in the left atrium around the LAA ostium; and a distal diameter sized to fit within the LAA ostium. The proximal and distal petal anchors include asymmetrical petals arranged like the petals of a flower configured to engage the wall of the LAA to anchor the implant. The implant is designed to be delivered to the heart using a catheter-based delivery system.

An occluder, an occluding system, and a conveying device are provided. The occluder includes an occluding frame. The occluding frame includes a first occluding unit, a middle portion occluding unit, a second occluding unit, and waist portions. Both ends of the middle portion occluding unit are connected to the first occluding unit and the second occluding unit, respectively, by the waist portions. A fixing member is sleeved on each waist portion. A channel is formed at a middle portion of each fixing member. The occluding frame has an inner cavity. A first opening is formed on the first occluding unit. A second opening is formed on the second occluding unit. The first opening, the channel, the inner cavity, and the second opening are communicated to form a path. A locking member can be omitted in the occluder.

An occluder device is provided for occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue, the device including a compliant balloon defining a fluid-tight balloon chamber and a balloon channel forming a longitudinal passage from a proximal to a distal side of the balloon, the balloon including a fluid port for filling a fluid into the balloon chamber. A tip and a base are coupled to the distal and the proximal sides of the balloon, respectively. At least one connecting strut is attached to the tip and to the base. An elongate actuator is disposed longitudinally slidable in the balloon channel and connected to the tip, and longitudinally slidable with respect to the base so as to set a distance between the tip and the base. A lock is configured to maintain the distance between the tip and the base. Other embodiments are also described.